Chul Kim
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations EGFR Gene Mutation, Nonsmall Cell Lung Cancer | Phase 1 / Phase 2 | 2016-10-01 |